Avricore Health Inc Stock Toronto S.E.
Equities
APH
CA92143R2046
Pharmaceuticals
Sales 2022 | 1.77M 1.3M | Sales 2023 | 3.49M 2.55M | Capitalization | 16.94M 12.42M |
---|---|---|---|---|---|
Net income 2022 | - 0 | Net income 2023 | - 0 | EV / Sales 2022 | 17.3 x |
Net cash position 2022 | 591K 433K | Net cash position 2023 | 247K 181K | EV / Sales 2023 | 4.79 x |
P/E ratio 2022 |
-37.7
x | P/E ratio 2023 |
-24.1
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 90.31% |
Managers | Title | Age | Since |
---|---|---|---|
Hector Bremner
CEO | Chief Executive Officer | - | 18-12-31 |
Kiki Smith
DFI | Director of Finance/CFO | - | 19-08-05 |
Rodger Seccombe
CTO | Chief Tech/Sci/R&D Officer | - | 20-12-07 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Hall
CHM | Chairman | 71 | 16-01-19 |
Robert Sindelar
BRD | Director/Board Member | 71 | 18-03-26 |
Christine Hrudka
BRD | Director/Board Member | - | 23-06-20 |
1st Jan change | Capi. | |
---|---|---|
+37.78% | 705B | |
+32.82% | 583B | |
-3.51% | 364B | |
+19.94% | 332B | |
+5.14% | 291B | |
+16.64% | 238B | |
-4.13% | 210B | |
+10.63% | 209B | |
+9.32% | 169B |